Listar INVESTIGACIÓN por autor "Fuentealba, Cynthia [Chile. Hospital de Carabineros]"
Mostrando ítems 1-4 de 4
-
A comparative performance analysis of total PSA, percentage free PSA, PSA velocity, and PSA density versus the detection of primary circulating prostate cells in predicting initial prostate biopsy findings in chilean men
Reyes, Eduardo [Chile. Universidad Diego Portales]; Orellana,Nelson [Chile. Hospital de Carabineros]; Fuentealba, Cynthia [Chile. Hospital de Carabineros]; Dueñas,Ricardo. [Chile. Hospital de Carabineros] (CIENCIAS, 2014)Introduction. PSA parameters have been used in an attempt to improve the diagnostic yield of prostate screening tests; the detection of primary malignant circulating prostate cells (CPCs) may improve the diagnostic yield ... -
Extended use of P504S positive primary circulating prostate cell detection to determine the need for initial prostate biopsy in a prostate cancer screening program in Chile
Reyes, Eduardo [Chile. Universidad Mayor]; Fuentealba, Cynthia [Chile. Hospital de Carabineros]; Jacob, Omar [Chile. Hospital de Carabineros]; Orellana, Nelson. [Chile. Hospital de Carabineros] (CIENCIAS, 2014)BACKGROUND: To determine the frequency of primary circulating prostate cells (CPC) detection according to age and serum PSA levels in a cohort of men undergoing screening for prostate cancer and to determine the diagnostic ... -
Limited improvement of incorporating primary circulating prostate cells with the CAPRA score to predict biochemical failure-free outcome of radical prostatectomy for prostate cancer
Aedo, Socrates [Chile. Universidad Finis Terrae]; Fuentealba, Cynthia [Chile. Hospital de Carabineros]; Orellana, Sebastián [Chile. Universidad Mayor. Facultad de Medicina] (CIENCIAS, 2016)OBJECTIVE: To establish a prediction model for early biochemical failure based on the Cancer of the Prostate Risk Assessment (CAPRA) score, the presence or absence of primary circulating prostate cells (CPC) and the number ... -
Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease
Reyes, Eduardo [Chile.Universidad Diego Portales]; Orellana, Nelson [Chile. Hospital de Carabineros]; Fuentealba, Cynthia [Chile. Hospital de Carabineros] (CIENCIAS, 2013)Introduction. Although 90% of prostate cancer is considered to be localized, 20%-30% of patients will experience biochemical failure (BF), defined as serum PSA >0.2 ng/mL, after radical prostatectomy (RP). The presence of ...